These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment. Hescot S; Paci A; Seck A; Slama A; Viengchareun S; Trabado S; Brailly-Tabard S; Al Ghuzlan A; Young J; Baudin E; Lombès M Horm Cancer; 2014 Oct; 5(5):312-23. PubMed ID: 25026941 [TBL] [Abstract][Full Text] [Related]
23. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients. Garg MB; Sakoff JA; Ackland SP J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2201-5. PubMed ID: 21719363 [TBL] [Abstract][Full Text] [Related]
24. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD). Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940 [TBL] [Abstract][Full Text] [Related]
25. [Decrease in the intensity of the EPR cytochrome P-450, adrenodoxine and free radical signals in the adrenal cortex of dogs under the effect of o,p-dichlorodiphenyldichloroethane]. Mikosha AS; Berezovskaia NN Probl Endokrinol (Mosk); 1983; 29(5):62-5. PubMed ID: 6647432 [TBL] [Abstract][Full Text] [Related]
27. [Insensitivity of purified glutathione reductase from adrenal cortex to o,p'-dichlorodiphenyldichloroethane]. Komissarenko VP; Chelnakova IS; Mikosha AS Ukr Biokhim Zh (1978); 1982; 54(4):400-4. PubMed ID: 7135497 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs. Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626 [TBL] [Abstract][Full Text] [Related]
29. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells. Asp V; Cantillana T; Bergman A; Brandt I Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879 [TBL] [Abstract][Full Text] [Related]
30. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma. Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies against bovine adrenal cytochrome P-450(11 beta) and cytochrome P-450SCC. Their isolation, characterization and application to immunohistochemical analysis of adrenal cortex. Sugano S; Ohnishi T; Hatae N; Ishimura K; Fujita H; Yamano T; Okamoto M J Steroid Biochem; 1985 Dec; 23(6A):1013-21. PubMed ID: 4094410 [TBL] [Abstract][Full Text] [Related]
32. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up. Kasperlik-Zaluska AA; Cichocki A J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (mitotane) and its analogs on feminizing adrenal neoplastic cells in culture. Fang VS Cancer Res; 1979 Jan; 39(1):139-45. PubMed ID: 761184 [TBL] [Abstract][Full Text] [Related]
34. [Design of heterologous mitochondria: import of cattle cytochrome P-450SCC precursors in plant mitochondria]. Luzikov VN; Novikova LA; Spiridonova VA; Isaeva LV; Whelan J; Hugosson M; Glaser E Biokhimiia; 1994 Jul; 59(7):1098-101. PubMed ID: 7948418 [TBL] [Abstract][Full Text] [Related]
35. [Chemical modification of cholesterol-hydroxylating cytochrome P-450 from adrenal cortex mitochondria with diethylpyrocarbonate]. Pikuleva IA; Usanov SA; Chashchin VL Biokhimiia; 1990 Apr; 55(4):665-73. PubMed ID: 2378912 [TBL] [Abstract][Full Text] [Related]
36. 22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol. Lambeth JD Mol Pharmacol; 1983 May; 23(3):743-7. PubMed ID: 6688121 [TBL] [Abstract][Full Text] [Related]
37. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma]. Lecka A; Ginalska-Malinowska M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662 [TBL] [Abstract][Full Text] [Related]
38. Biphasic hormonal responses to the adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE in human cells. Asp V; Ullerås E; Lindström V; Bergström U; Oskarsson A; Brandt I Toxicol Appl Pharmacol; 2010 Feb; 242(3):281-9. PubMed ID: 19900470 [TBL] [Abstract][Full Text] [Related]
39. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH). Fottner C; Engelhardt D; Weber MM Horm Metab Res; 1999; 31(2-3):203-8. PubMed ID: 10226803 [TBL] [Abstract][Full Text] [Related]
40. Toxicity, ultrastructural effects, and metabolic studies with 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane(o,p'-DDD) and its methyl analog in the guinea pig and rat. Jensen BL; Caldwell MW; French LG; Briggs DG Toxicol Appl Pharmacol; 1987 Jan; 87(1):1-9. PubMed ID: 3798445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]